“This study was conducted as a real-world efficacy study in one of the most challenging epidemiologic settings,” said Dr. Dan Barouch, a virologist at Beth Israel Deaconess Medical Center in […]
Study finds J&J vaccine has an efficacy of up to 71% against hospitalization from the highly contagious strain. Read Article
“The more breakthroughs you have, the easier it is to determine,” Katy Stephenson. Read Article
Dan Barouch, told ABC News in late May that the pharmaceutical companies have an economic incentive and that a decision on booster shots should be made based on public health […]
The Johnson & Johnson vaccine appears to provide strong protection against the Delta variant that not only doesn’t wane over time but seems to grow stronger. See Article
The Johnson & Johnson coronavirus vaccine provides immunity that lasts at least eight months, and it appears to provide adequate protection against the worrying Delta variant, the company said in […]
Johnson & Johnson announced that its COVID-19 vaccine “”generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.” The vaccine was developed in […]
Johnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly. Read Article
The vaccine also produced long-lasting immune responses, researchers said. Booster shots seem unnecessary, at least for now. Read Article
